[Pr-1]The Mission of Neurology - Its Past, Present, and Future
○Ryosuke Takahashi(Department of Neurology, Kyoto University Graduate School of Medicine)
NEURO62
May 19 - May 22, 2021Kyoto International Conference Center
You can search for presentations in this event.
Search
NEURO62
May 19 - May 22, 2021Kyoto International Conference Center
You can search for presentations in this event.
SearchSearch Results(1,770)
[VPr-1]Transmission of prion and prion-like proteins in humans: an emerging concept of “acquired CAA”
○Masahito Yamada(Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences)
[PL-1]Toward the Mysteries of Sleep
○Masashi Yanagisawa(WPI-IIIS, University of Tsukuba, Japan)
[SPL-01-1]The Therapeutic Landscape for Amyotrophic Lateral Sclerosis
○Lucie Bruijn(Translational Medicine, Novartis Gene Therapies, UK)
[SPL-02-1]Parkinson's disease - from a street view to disease modification
○Werner H. Poewe(Dept of Neurology, Medical University of Innsbruck, Austria)
[SPL-03-1]APOE4-associated cognitive impairment: the role of blood-brain barrier dysfunction
○Berislav Zlokovic(Department of Physiology and Neuroscience, Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, USA)
[SL-01-1]Cerebral Amyloid Angiopathy and Alzheimer Disease: One Peptide, Two Pathways
○Steven M. Greenberg(Department of Neurology, Massachusetts General Hospital / Harvard Medical School, USA)
[SL-02-1]A True Story of Innovation Generated by One Inventor of Medicine
○Ryuji Ueno(M.D., Ph.D. and Ph.D., Inventor of Medicine, Professor, Graduate School of Medicine, Kyoto University, Japan)
[AW-1]Advances in Translational Research in Myotonic Dystrophy
○Masayuki Nakamori(Dept. of Neurology, Osaka University Graduate School of Medicine, Japan)
[AW-2]Taurine therapy for stroke-like episodes of MELAS mitochondrial disease
○Yoshihide Sunada(Department of Neurology, Kawasaki Medical School, Japan)
[AW-3]The population-based cohort (Nakajima study) and the educational program (NINPRO) for dementia
○Masahito Yamada(Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences, Japan)
[NFS-01-1]Precision measurement of fluid biomarkers for the multicenter imaging cohort study (MABB)
○Takahiko Tokuda1, Multicenter Alliance for Brain Biomarkers2(1.Department of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Japan, 2.The Multicenter Alliance for Brain Biomarkers)
[NFS-01-2]Dissecting pathophysiology of Parkinson's disease with multimodal neuroimaging
○Nobukatsu Sawamoto(Department of Human Health Sciences, Kyoto University Graduate School of Medicine, Japan)
[NFS-01-3]Coevolution of neurophysiology, neuroimaging and CSF biomarkers in early staged Alzheimer's disease
○Takenobu Murakami1,2, Yoshikazu Ugawa3(1.Division of Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Japan, 2.Department of Neurology, Faculty of Medicine, Fukushima Medical University, Japan, 3.Department of Human Neurophysiology, Faculty of Medicine, Fukushima Medical University)
[NFS-01-4]Tau imaging in typical and atypical Alzheimers disease
○Pedro Rosa-Neto1,2(1.McGill University, Canada, 2.McGill Centre for Studies in Aging, Canada)
[NFS-01-5]Multimodal Database for Parkinson Disease in China
○Tao Wu(Capital Medical University, China)
[NFS-02-1]iPSCs-based stratification, drug development and clinical trial for ALS
○Hideyuki Okano(Keio University School of Medicine, Japan)
[NFS-02-2]Applications of AI to Elucidate Mechanisms of Neurodegenerative Disease in Models and Patients
○Steve Finkbeiner(Gladstone Institutes, UCSF, USA)
[NFS-02-3]AI-based live-cell-image analysis for spinal and bulbar muscular atrophy pathology
○Kenji Sakakibara1, Yuta Imai2, Kentaro Sahashi1, Ryuji Kato2, Masahisa Katsuno1(1.Department of Neurology, Nagoya University Graduate School of Medicine, Japan, 2.Department of Basic Medicinal Sciences, Graduate School of Pharmaceutical Sciences, Nagoya University)
[NFS-02-4]Big data-driven research of neurodegenerative diseases
○Hitoshi Okazawa(Department of Neuropathology, Tokyo Medical and Dental University, Japan)
[NFS-02-5]Deep learning of medical imaging data for early prediction of Alzheimer's disease dementia
○Yong Fan(Perelman School of Medicine, University of Pennsylvania, USA)
[NFS-02-6]Challenges to Personalized Medicine by AI and Big Data - Genomes to Networks
○Satoru Miyano(M&D Data Science Center, Tokyo Medical and Dental University, Japan)
[NFS-03-1]The gender differences in the centenarians with extreme aging are affected by APOEε4 alleles
○Yoshinori Nishimoto(Department of Neurology, Keio University, School of Medicine, Japan)
[NFS-03-2]ApoE4 disrupts microcirculation in the white matter
○Yorito Hattori(Department of Neurology, National Cerebral and Cardiovascular Center, Japan)
[NFS-03-3]ApoE4 in Vascular Mural Cells and Brain Homeostasis
○Yu Yamazaki(Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Japan)
[NFS-03-4]Differential effect of APOE genotype on blood-brain barrier integrity
○Yuto Uchida1,2, Noriyuki Matsukawa1(1.Department of Neurology, Nagoya City University Graduate School of Medical Sciences, Japan, 2.Department of Neurology, Toyokawa City Hospital, Japan)
[NFS-04-1]Structure of alpha-synculein fibrils in the brain
○Katsuya Araki1,2(1.Toyonaka Municipal Hospital, Japan, 2.Department of Neurology, Osaka University Graduate School of Medicine, Japan)
[NFS-04-2]Prion-like propagation of pathological alpha-synuclein and tau proteins
○Masato Hasegawa(Department of Brain and Neurosciences, Tokyo Metropolitan Institute of Medical Science, Japan)
[NFS-04-3]Identification of disease-specific alpha-synuclein seeds in serum by IP-RT-QuIC
○Ayami Okuzumi1, Taku Hatano1, Nobuyuki Nukina2, Nobutaka Hattori1(1.Department of Neurology, Juntendo University School of Medicine, Japan, 2.Laboratory of Structural Neuropathology, Graduate School of Brain Science, Doshisha University)
[NFS-04-4]Quantum-dot-labeled synuclein seeds assay identifies drugs modulating prion-like transmission
○Nobuyuki Nukina(Doshisha University Graduate School of Brain Science, Japan)
[NFS-04-5]Deconstructing and Reconstructing Lewy Bodies: New insights into the role of alpha-synuclein in PD
○Hilal A. Lashuel(École Polytechnique Fédérale de Lausanne (EPFL), Switzerland)
[NFS-05-1]Expanding mechanisms and therapeutic targets for ALS
○Aaron D. Gitler(Department of Genetics, Stanford University, USA)
[NFS-05-2]Defect in monomer/multimer balance induces TDP-43 pathology in ALS
○Koji Yamanaka(Resaerch Institute of Environmental Medicine, Nagoya University, Japan)
[NFS-05-3]TDP-43 transports ribosomal protein mRNA to regulate local translation in neuronal axons
○Seiichi Nagano(Department of Neurotherapeutics, Osaka University Graduate School of Medicine, Japan)
[NFS-05-4]Optogenetic modulation of TDP-43 oligomerization accelerates ALS-related pathologies in a fish model
○Kazuhide Asakawa1, Hiroshi Handa1, Koichi Kawakami2,3(1.Tokyo Medical University, Department of Chemical Biology, Japan, 2.National Institute of Genetics, Division of Molecular and Developmental Biology, 3.SOKENDAI, Department of Genetics)
[NFS-05-5]Alteration of Tau metabolism through FUS in FTLD
○Shinsuke Ishigaki1,2(1.Department of Neurology, Nagoya University Graduate School of Medicine, Japan, 2.Brain and Mind Research Center, Nagoya University, Japan)
[HT-01-1]Medical management, and hopefully, prevention of epilepsy: the cutting edge and future perspectives
○Masako Kinoshita1,2(1.Department of Neurology, National Hospital Organization Utano National Hospital, Japan, 2.Department of Neurology, Nara Medical University, Japan)
[HT-01-2]Evaluation of drug toxicity and efficacy based on human iPSC-derived neuronal activities
○Ikuro Suzuki1,2(1.Department of Electronics, Tohoku Institute of Technology, Japan, 2.RIKEN BioResource Research Center, Japan)
[HT-01-3]Closed Loop Neuromodulation for the Treatment of Epilepsy with Responsive Neurostimulation
○Dileep R. Nair(Epilepsy Center, Cleveland Clinic, USA)
[HT-01-4]Stereo-EEG guided thermocoagulation
○Koichi Hagiwara1, Hiroshi Shigeto1,2, Naoki Akamatsu1,3, Shinji Ohara4(1.Epilepsy and Sleep Center, Fukuoka Sanno Hospital, Japan, 2.Division of Medical Technology, Department of Health Sciences, Graduate School of Medical Sciences, Kyushu University, 3.Epilepsy Center, International University of Health and Welfare Narita Hospital, 4.Department of Neurosurgery, Fukuoka Sanno Hospital)
[HT-02-1]Enactment of the Stroke and Cardiovasular Disease Control Act in Japan
○Kazuo Minematsu1,2(1.Headquarters of the Iseikai Medical Corporation, Japan, 2.Japan Stroke Association, Japan)
[HT-02-2]Goals of stroke awareness to prevent, save lives and reduce disabilities
○Hidehiro Takekawa1,2, Hirofumi Nakayama1,3, Yoichiro Hashimoto1,4, Kazuo Minematsu1,5(1.The Japan Stroke Association, Japan, 2.Dokkyo Medical University, Japan, 3.Nakayama Clinic, 4.Kumamoto City Hospital, 5.Iseikai Medical Corporation)
[HT-02-3]Stroke systems of care
○Hiroshi Yamagami(NHO Osaka National Hospital, Japan)
[HT-02-4]Medical system of stroke care
○Yasuyuki Iguchi(Department of Neurology, the Jikei University School of Medicine, Japan)
[HT-02-5]Collaboration between medical care and welfare and human resource development
○Shigeru Fujimoto(Division of Neurology, Department of Medicine, Jichi Medical University, Japan)
[HT-02-6]Promotion of registry and research
○Teruyuki Hirano(Department of Stroke and Cerebrovascular Medicine, Kyorin University School of Medicine, Japan)
[HT-02-7]Future initiatives based on the Cerebrovascular and Cardiovascular Disease Control Act
○Megumu Mori, Masanari Kuwabara, Shigekazu Komoto(Cancer and Disease Control Division, Health Service Bureau, Ministry of Health, Labour and Welfare, Japan)
[HT-03-1]Development of therapeutic strategies to repair neuronal network for the CNS diseases
○Toshihide Yamashita(Department of Molecular Neuroscience, Graduate School of Medicine, Osaka University, Japan)
[HT-03-2]Neurological disorders of HTLV-1 Associated Myelopathy/Tropical Spastic Paraperesis
○Natsumi Araya1, Satoko Aratani1,2, Naoko Yagishita1, Junji Yamauchi1, Tomoo Sato1, Yoshihisa Yamano1,3(1.Institute of Medical Science, St. Marianna University School of Medicine, Japan, 2.LSI Medience Co., 3.Division of Neurology, Department of Internal Medicine, St. Marianna University School of Medicine)
[HT-03-3]Pathogenesis and treatment of anti-AQP4 antibody-positive neuromyelitis optica
○Ichiro Nakashima(Division of Neurology, Tohoku Medical and Pharmaceutical University, Japan)
1,770 results ( 1 - 50 )
- 1
- ...